Michael Grunkin, Ph.D.

Chief Executive Officer Dr. Michael Grunkin is founder and managing director of Visiopharm. He received his Ph.D in image analysis from the Technical University of Denmark in 1993.

His post-doctoral work was carried out on Massachusetts Institute of Technology and Harvard Medical School, where he combined a strong theoretical and practical background in image analysis with applications from the life-sciences. 

From 1996, he was the technical founder of two Danish companies developing advanced image analysis technology for diagnosing osteoporosis and various diseases manifesting themselves on the human retina. In 2001, he co-founded Visiopharm, which is focused on the development of general as well as application-specific image analysis solutions for the life-sciences.

Johan Doré Hansen, M. Sc.

Chief Technical Officer Johan Doré Hansen is co-founder and CTO in Visiopharm. He received his Master's Degree in image analysis from the Technical University of Denmark in 1995.

Until 1999, he developed high-speed industrial inspection systems though his own company, Imaging.

One of his major achievements is a hardwood parquet sorting system, which is currently running on several production lines. In 1999, he entered the field of life-science image analysis, and was the driving force behind the development of algorithms for diagnosing diseases manifesting themselves on the human retina. In 2001, he co-founded Visiopharm.

Kristian Dalhof Nielsen

Chief Financial Officer Kristian Dalhof Nielsen is the CFO in Visiopharm. He received his M.Sc. Economics and Business Administration from the Copenhagen Business School in 2003.

Kristian’s main focus has always been to secure data quality and business support, as well as creating transparency and objectivity in his positions.

Kristian has proven instrumental in doing this in different industries such as Fuel, Market analysis, IT and Insulation. Prior to joining Visiopharm, Kristian worked for Rockwool Scandinavia.

Thomas AhlIMG

Thomas Ahl, Ph.D.

Chief Operating Officer Thomas Ahl is Chief Operating Officer. Thomas joined Visiopharm in February 2018 from a position as Site Lead of the development and production facility of Radiometer in Basel, Switzerland. Thomas Ahl has more than 25 years’ professional experience in technology innovation, product development, market evaluation and asset protection. In the last 14 years Thomas Ahl has been driving results using the lean leadership principles of the Danaher business system.

Thomas Ahl holds a PhD in immunology and microbiology.

Andreas Schønau

Chief Scientific Officer Andreas Schønau is the CSO of Visiopharm. He received his M.Sc. in Engineering from the Technical University of Denmark in 1997, and has since added diploma degrees in Business Administration and Management (EBA, 2002) and Information Technology (ITD, 2011) from the Engineering College of Copenhagen. Andreas has a solid background in technology and product development for the diagnostic and medical device industry.

He has been responsible for product development for Molecular Pathology with Danish based cancer diagnostic legacy Dako now Agilent technologies, including co-development projects with some of the world's largest pharmaceutical companies, and has brought several IVD class III products through FDA approval.

Andreas is a strategic and innovative thinker within the fields of diagnostics, personalized medicine and automation.

Louise Armstrong

Chief Commerical Officer Louise Armstrong is the CCO in Visiopharm. She joined in May 2019 to lead the global commercial organization, supporting Visiopharm’s strategic growth initiatives.

Louise has two decades of imaging and analysis experience and has successfully commercialized cellular and tissue imaging systems, software and services, building commercial teams and partnerships across Europe, the Americas, and Asia-Pacific. Louise has previously held several senior global sales and product management positions in PerkinElmer and Andor Technology.

Louise is a Fellow of the Royal Society of Chemistry (FRSC), a Chartered Chemist (CChem) and has a Ph.D. in Analytical Chemistry.

Adrian Arechiga, Ph.D.

Chief Marketing Officer Adrian Arechiga is the Chief Marketing Officer, where he defines product, marketing and brand strategy. Adrian brings international experience and knowledge of the life sciences, diagnostic and biopharma markets. He has built his career spanning technical sales, global product management, global marketing, and brand development roles.

Adrian holds a Ph.D. in Molecular Immunology, an MBA in Sustainable Management and an Executive Certification in Digital Marketing Strategies.

Adrian Portrait